Cite

    Micheal Ward et al.. “Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes.” Scientific reports, vol. 7, no. 1, 2017, pp. 1–14. http://access.bl.uk/ark:/81055/vdc_100086838040.0x00002a